8W2L
TRPM7 structure in complex with anticancer agent CCT128930 in closed state
Summary for 8W2L
Entry DOI | 10.2210/pdb8w2l/pdb |
EMDB information | 43751 |
Descriptor | Green fluorescent protein,Transient receptor potential cation channel subfamily M member 7, (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, CHOLESTEROL, ... (7 entities in total) |
Functional Keywords | transient receptor potential m family member 7, trp, channel, trpm7, trp channels, membrane protein, cct128930 |
Biological source | Aequorea victoria More |
Total number of polymer chains | 4 |
Total formula weight | 747574.04 |
Authors | Nadezhdin, K.D.,Sobolevsky, A.I. (deposition date: 2024-02-20, release date: 2024-04-17, Last modification date: 2024-11-13) |
Primary citation | Nadezhdin, K.D.,Correia, L.,Shalygin, A.,Aktolun, M.,Neuberger, A.,Gudermann, T.,Kurnikova, M.G.,Chubanov, V.,Sobolevsky, A.I. Structural basis of selective TRPM7 inhibition by the anticancer agent CCT128930. Cell Rep, 43:114108-114108, 2024 Cited by PubMed Abstract: TRP channels are implicated in various diseases, but high structural similarity between them makes selective pharmacological modulation challenging. Here, we study the molecular mechanism underlying specific inhibition of the TRPM7 channel, which is essential for cancer cell proliferation, by the anticancer agent CCT128930 (CCT). Using cryo-EM, functional analysis, and MD simulations, we show that CCT binds to a vanilloid-like (VL) site, stabilizing TRPM7 in the closed non-conducting state. Similar to other allosteric inhibitors of TRPM7, NS8593 and VER155008, binding of CCT is accompanied by displacement of a lipid that resides in the VL site in the apo condition. Moreover, we demonstrate the principal role of several residues in the VL site enabling CCT to inhibit TRPM7 without impacting the homologous TRPM6 channel. Hence, our results uncover the central role of the VL site for the selective interaction of TRPM7 with small molecules that can be explored in future drug design. PubMed: 38615321DOI: 10.1016/j.celrep.2024.114108 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (2.45 Å) |
Structure validation
Download full validation report
